MCID: THY050
MIFTS: 14

Thyroid Cancer, Childhood malady

Categories: Rare diseases, Cancer diseases

Aliases & Classifications for Thyroid Cancer, Childhood

Aliases & Descriptions for Thyroid Cancer, Childhood:

Name: Thyroid Cancer, Childhood 50
Thyroid Cancer, Pediatric 50
Childhood Thyroid Cancer 50
Pediatric Thyroid Cancer 50

Classifications:



Summaries for Thyroid Cancer, Childhood

MalaCards based summary : Thyroid Cancer, Childhood, also known as thyroid cancer, pediatric, is related to thyroid cancer and thyroiditis. An important gene associated with Thyroid Cancer, Childhood is SLC2A1 (Solute Carrier Family 2 Member 1). The drugs Imatinib Mesylate and Hormone Antagonists have been mentioned in the context of this disorder. Affiliated tissues include thyroid.

Related Diseases for Thyroid Cancer, Childhood

Diseases related to Thyroid Cancer, Childhood via text searches within MalaCards or GeneCards Suite gene sharing:

id Related Disease Score Top Affiliating Genes
1 thyroid cancer 9.6
2 thyroiditis 9.6

Symptoms & Phenotypes for Thyroid Cancer, Childhood

Drugs & Therapeutics for Thyroid Cancer, Childhood

Drugs for Thyroid Cancer, Childhood (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 77)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1 Imatinib Mesylate Phase 4 123596
2 Hormone Antagonists Phase 4,Phase 2,Phase 1
3 Hormones Phase 4,Phase 2,Phase 1
4 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 2,Phase 1
5
Vincristine Approved, Investigational Phase 3 2068-78-2, 57-22-7 5978
6
Cisplatin Approved Phase 3,Phase 2 15663-27-1 84093 441203 2767
7
Cyclophosphamide Approved, Investigational Phase 3 50-18-0, 6055-19-2 2907
8
Succinylcholine Approved Phase 3 306-40-1 5314
9
Lomustine Approved Phase 3 13010-47-4 3950
10 Alkylating Agents Phase 3
11 Neuromuscular Agents Phase 3
12 Neuromuscular Blocking Agents Phase 3
13 Neuromuscular Depolarizing Agents Phase 3
14 Peripheral Nervous System Agents Phase 3
15 Immunosuppressive Agents Phase 3
16 Antimitotic Agents Phase 3
17 Antirheumatic Agents Phase 3
18 Antineoplastic Agents, Alkylating Phase 3
19 Antineoplastic Agents, Phytogenic Phase 3
20
Ritonavir Approved, Investigational Phase 2 155213-67-5 392622
21
Indinavir Approved Phase 2 150378-17-9 5362440
22
Doxorubicin Approved, Investigational Phase 2 23214-92-8 31703
23
Tamoxifen Approved Phase 2 10540-29-1 2733526
24
Sorafenib Approved, Investigational Phase 2 284461-73-0 216239 406563
25
Dexamethasone Approved, Investigational, Vet_approved Phase 2 50-02-2 5743
26
Acetaminophen Approved Phase 2 103-90-2 1983
27
Diphenhydramine Approved Phase 2 58-73-1, 147-24-0 3100
28
Promethazine Approved Phase 2 60-87-7 4927
29
Niacin Approved, Investigational, Nutraceutical Phase 2 59-67-6 938
30
Nicotinamide Approved, Nutraceutical Phase 2 98-92-0 936
31
Folic Acid Approved, Nutraceutical, Vet_approved Phase 2 59-30-3 6037
32
Doxil Approved June 1999 Phase 2 31703
33
protease inhibitors Phase 2
34 HIV Protease Inhibitors Phase 2
35 Cytochrome P-450 CYP3A Inhibitors Phase 2
36 Cytochrome P-450 Enzyme Inhibitors Phase 2
37 Anti-HIV Agents Phase 2
38 Anti-Infective Agents Phase 2
39 Liver Extracts Phase 2
40 Anti-Retroviral Agents Phase 2
41 Antiviral Agents Phase 2
42 Selective Estrogen Receptor Modulators Phase 2
43 Nicotinic Acids Phase 2
44 Topoisomerase Inhibitors Phase 2
45 Trace Elements Phase 2
46 Vitamin B Complex Phase 2
47 Estrogen Antagonists Phase 2
48 Anti-Bacterial Agents Phase 2
49 Vitamins Phase 2
50 Estrogen Receptor Modulators Phase 2

Interventional clinical trials:

(show all 17)
id Name Status NCT ID Phase
1 Assessment Of Gh-Igf-1 Axis In Children With Chronic Myelogenous Leukemia (CML) In Remission Unknown status NCT01901666 Phase 4
2 Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma Completed NCT00085735 Phase 3
3 External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases Unknown status NCT00637637 Phase 2
4 Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer Completed NCT01502410 Phase 2
5 Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors Completed NCT00002608 Phase 2
6 Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer Active, not recruiting NCT00445965 Phase 2
7 Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors Not yet recruiting NCT02867592 Phase 2
8 Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors Active, not recruiting NCT01709435 Phase 1
9 Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer Terminated NCT00002947 Phase 1
10 Effect of Childhood Radioiodine Therapy on Salivary Function Unknown status NCT02375451
11 Lactation Outcomes Among Survivors of Pediatric Cancer Completed NCT02399956
12 Radiation Exposure and Thyroid Disease in Kazakhstan Completed NCT00480428
13 Hereditary Risk Factors for Thyroid Cancer Recruiting NCT02747888
14 Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors and Hematopoietic Stem Cell Transplant Recipients Recruiting NCT00504218
15 Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford Recruiting NCT01793168
16 Thyroid Abnormalities Associated With Exposure to Atmospheric Emissions of Radioactive Iodine Terminated NCT00342693
17 Cardiometabolic Status in Childhood Acute Lymphoblastic Leukemia Withdrawn NCT01688752

Search NIH Clinical Center for Thyroid Cancer, Childhood

Genetic Tests for Thyroid Cancer, Childhood

Anatomical Context for Thyroid Cancer, Childhood

MalaCards organs/tissues related to Thyroid Cancer, Childhood:

39
Thyroid

Publications for Thyroid Cancer, Childhood

Variations for Thyroid Cancer, Childhood

Expression for Thyroid Cancer, Childhood

Search GEO for disease gene expression data for Thyroid Cancer, Childhood.

Pathways for Thyroid Cancer, Childhood

GO Terms for Thyroid Cancer, Childhood

Sources for Thyroid Cancer, Childhood

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....